Gentamicin

Chemical formula: C₂₁H₄₃N₅O₇  Molecular mass: 1,390.728 g/mol  PubChem compound: 3467

Therapeutic indications

Gentamicin is indicated for:

Urinary tract infections

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Urinary tract infectious disease and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary tract infections

Population group: only infants (40 days - 1 year old)

Urinary tract infectious disease and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary tract infections

Population group: only newborns (0 - 40 days old)

Urinary tract infectious disease and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Burn and wound infections

Population group: only infants (40 days - 1 year old)

at least one of
Local infection of wound
Burn
and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Burn and wound infections

Population group: only newborns (0 - 40 days old)

at least one of
Local infection of wound
Burn
and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Burn and wound infections

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Local infection of wound
Burn
and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Abscess

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Abscess

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Abscess

Population group: only infants (40 days - 1 year old)

Abscess

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Abscess

Population group: only newborns (0 - 40 days old)

Abscess

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Subacute bacterial endocarditis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Subacute bacterial endocarditis and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Subacute bacterial endocarditis

Population group: only infants (40 days - 1 year old)

Subacute bacterial endocarditis and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Subacute bacterial endocarditis

Population group: only newborns (0 - 40 days old)

Subacute bacterial endocarditis and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Respiratory tract infection

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Respiratory tract infection and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Respiratory tract infection

Population group: only infants (40 days - 1 year old)

Respiratory tract infection and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Respiratory tract infection

Population group: only newborns (0 - 40 days old)

Respiratory tract infection and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gynaecological infections

Population group: women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Female genital infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eye infection

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Eye infection and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Infection of ear

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Ear infection and additionally Gentamicin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Gentamicin is contraindicated in the following cases:

Hypersensitivity to aminoglycosides

Aminoglycoside allergy

Myasthenia gravis

Myasthenia gravis

Perforation of tympanic membrane

Perforation of tympanic membrane

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: GENTAMICIN Eye / Ear drops
Summary of Product Characteristics (SPC) 2018: GENTAMICIN Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈